DataMEDS AI, Inc. (MEDS)
$2.75+3.00%Close
Snapshot
- 1 week
- -9.2%-8.1% vs SPY
- 1 month
- -26.9%-27.8% vs SPY
- Market cap
- $6.8M
- P/E
- negindustry 14.3
- P/B
- -0.4
- EV/EBITDA
- -0.7
- Short % float
- 50.0%
- Days to cover
- 1.0
- Short change
- +21.9%
Signal: Call, Regime, Alignment, Score, ATR trend, HiLo flip, Coil, Exhaustion, Topping · Technicals (EMA stack, slope, squeeze, stochastic, MACD-Z, DI+) · Price & returns: 3 months, Year to date, 1 year
Price & returns: 3 years, 5 years
Signal: Composite · Performance (Q-Score, Sharpe, Sortino, Calmar, CAGR, drawdown, alpha)
Signal evidence
Best Combo (today's action, held-out profit factor and family votes) · White Arrow (the call, its profit factor and closed trades) · Regime (today's regime and the regime model's profit factor) · Exhaustion (whether buyers or sellers are stretched today and the latest release)
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
Company
About
DataMEDS AI, Inc. (MEDS). DataMEDS AI is a Health IT company focused on the vertical integration of technology, pharmacy, pharmaceutical-adjacent, and telemedicine business units. The company incorporates its artificial intelligence platform EinsteinRx⢠and blockchain-enabled smart contacts platform PharmacyChain⢠to optimize the prescription medicines reimbursement and dispensing journey.
SEC filingsCIK 2030763
Profile
SectorHealthcare
IndustryMedical - Distribution
ExchangeNASDAQ
CountryUS
CEOPrashant Patel
IPOFeb 21, 2025
Employees31
Shares outstanding2.5M
Float1.1M
Free float-
Websitedatamedsai.com
Key executives
- Gerald E. CommissiongInterim Co-Chief Executive Officer
- Shafaat PiraniChief Clinical OfficerUSD 275K
- Srini KallaChief Technology OfficerUSD 233K
- Eric Michael SherbInterim-CFOUSD 182K
- Prashant PatelInterim Co-CEO, President & DirectorUSD 13K
- Nikul PanchalSenior Vice President of Pharmacy
Fundamentals
SCORES & PROFILE
FUND, Value, Growth and GARP scores and the archetype
ROIC-
REV YoY-78.2%
ROE-
EPS YoY-
ROA-269.5%
GROSS-125
OP-719
NET-1100
VALUATION
P/E TTM-0.06
P/E FWD-
SECTOR PE20.97
INDUSTRY PE14.31
P/B-0.36
P/FCF-
EV/EBITDA-0.66
EV/EBIT-
FCF YIELD-
TRUE FCF YLD-
PEG-
BUYBACK0.00%
Risk
INT COV-9.7×
D/E-
ALTMAN Z-12.58
CURR RATIO0.14
ND/EBITDA-
INTEREST COVERAGE < 1.5X (-9.72X)NET INCOME (TTM) < 0
